Genital Inflammation and the Risk of HIV Acquisition in Women

Clinical Infectious Diseases

Volumn 61, Issue 2, 2015, Pages 260-269

  Masson, Lindi ^a,b   Passmore, Jo Ann S ^a,b,c   Liebenberg, Lenine J ^a   Werner, Lise ^a   Baxter, Cheryl ^a   Arnold, Kelly B ^d   Williamson, Carolyn ^a,b   Little, Francesca ^b   Mansoor, Leila E ^a   Naranbhai, Vivek ^a   Lauffenburger, Douglas A ^d   Ronacher, Katharina ^e   Walzl, Gerhard ^e   Garrett, Nigel J ^a   Williams, Brent L ^f   Couto Rodriguez, Mara ^f   Hornig, Mady ^f   Lipkin, W Ian ^f   Grobler, Anneke ^a   Abdool Karim, Quarraisha ^a,f   Abdool Karim, Salim S ^a,f   more..

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Massachusetts Institute of Technology Cambridge   (United States)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f Department of Medicine   (United States)

Author keywords

cytokine; female genital tract; HIV transmission; inflammation

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; TENOFOVIR; TUMOR NECROSIS FACTOR ALPHA; CCL2 PROTEIN, HUMAN; CHEMOKINE; CYTOKINE; IL10 PROTEIN, HUMAN; TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICAN; UROGENITAL TRACT INFECTION; UTERINE CERVIX CYTOLOGY; AFRICA; BLOOD; DISEASE PREDISPOSITION; FEMALE GENITAL SYSTEM; GENETICS; GENITAL DISEASES, FEMALE; IMMUNOLOGY; INFLAMMATION; SOUTH AFRICA; TRANSMISSION; UTERINE CERVICITIS; UTERINE CERVIX; VAGINA; VAGINAL LAVAGE; VAGINITIS; VIROLOGY; YOUNG ADULT;

AFRICA; CERVIX UTERI; CHEMOKINE CCL2; CHEMOKINES; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; GENITAL DISEASES, FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICITIS; VAGINA; VAGINAL DOUCHING; VAGINITIS; YOUNG ADULT;

EID: 84929698148     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ298     Document Type: Article

References (41)

1. UNAIDS. The gap report. Available at: http://www.unaids.org/en/media/ unaids/contentassets/documents/unaidspublication/2014/UNAIDS-Gap- report-en.pdf. Accessed 15 August 2014.
2. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2010. Available at: http://www.unaids.org/globalreport/. Accessed 11 February 2014.
3. Department of Health. The 2012 national antenatal sentinel HIV & herpes simplex type-2 prevalence survey in South Africa. Pretoria: Department of Health, 2014. Available at: http://www.health-e.org.za/wpcontent/ uploads/2014/05/ASHIVHerp-Report2014-22May2014.pdf. Accessed 13 February 2015.
4. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168-74.
5. Abdool Karim Q, Kharsany ABM, Frohlich JA, et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol 2011; 40: 922-30.
6. Abdool Karim SS. An AIDS-free generation? Science 2012; 337:133.
7. Jewkes RK, Dunkle K, Nduna M, Shai N. Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study. Lancet 2010; 376:41-8.
8. Boily MC, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 2009; 9:118-29.
9. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
10. Li Q, Estes JD, Schlievert PM, et al. Glycerol monolaurate prevents mucosal SIV transmission. Nature 2009; 458:1034-8.
11. Mlisana K, Naicker N,Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis 2012; 206:6-14.
12. Masson L, Mlisana K, Little F, et al. Defining genital tract cytokine signatures of sexually transmitted infections and bacterial vaginosis in women at high risk of HIV infection: a cross-sectional study. Sex Transm Infect 2014; 90:580-7.
13. Roberts L, Passmore JS, Mlisana K, et al. Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women. J Infect Dis 2012; 205:194-203.
14. Columb MO, Sagadai S. Multiple comparisons. Curr Anaesth Crit Care 2006; 17:233-6.
15. Lau KS, Juchheim AM, Cavaliere KR, et al. In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-?-induced apoptosis and proliferation by MAPKs. Sci Signal 2011; 4:ra16.
16. Abbas AK, Lichtman AH. Cytokines. In: Abbas AK, Lichtman AH, eds. Cellular and molecular immunology. 5th ed. 2005:247-64, 271-2.
17. Tocci MJ, Schmidt JA. Interleukin 1: structure and function. In: Remick DGFriedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997:1-19.
18. Cox G, Gauldie J. Interleukin-6. In: Remick DG, Friedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997: 81-92.
19. Appasamy PM. Interleukin-7 and lymphopoiesis. In: Remick DG, Friedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997:101-13.
20. Kunkel SL, Lukacs NW, Chensue SW, Strieter RM. Chemokines and the inflammatory response. In: Remick DG, Friedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997:121-9.
21. Powrie F, Bean A, Moore KW. Interleukin-10. In: Remick DG, Friedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997:143-9.
22. Tracey KJ. Tumor necrosis factor. In: Remick DG, Friedland JS, eds. Cytokines in health and disease. 2nd ed. Revised and Expanded. 1997: 223-33.
23. Stanford MM, Issekutz TB. The relative activity of CXCR3 and CCR5 ligands in T lymphocyte migration: concordant and disparate activities in vitro and in vivo. J Leukoc Biol 2003; 74:791-9.
24. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 2005; 206:306-35.
25. Dieu-Nosjean MC, Vicari A, Lebecque S, Caux C. Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines. J Leukoc Biol 1999; 66:252-62.
26. Mueller A, Strange PG. The chemokine receptor, CCR5. Int J Biochem Cell Biol 2004; 36:35-8.
27. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1?, and MIP-1? as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995; 270:1811-5.
28. Hirbod T, Nilsson J, Andersson S, et al. Upregulation of interferon-? and RANTES in the cervix of HIV-1-seronegative women with highrisk behavior. J Acquir Immune Defic Syndr 2006; 43:137-43.
29. Kaul R, Ball TB, Hirbod T. Defining the genital immune correlates of protection against HIV acquisition: co-infections and other potential confounders. Sex Transm Infect 2011; 87:125-30.
30. Narimatsu R, Wolday D, Patterson BK. IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 2005; 21:228-33.
31. Castle PE, Hildesheim A, Bowman FP, et al. Cervical concentrations of interleukin-10 and interleukin-12 do not correlate with plasma levels. J Clin Immunol 2002; 22:23-7.
32. Lajoie J, Juno J, Burgener A, et al. A distinct cytokine and chemokine profile at the genital mucosa is associated with HIV-1 protection among HIV-exposed seronegative commercial sex workers. Mucosal Immunol 2012; 5:277-87.
33. Scholes D, Daling JR, Stergachis A, et al. Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol 1993; 81:601-6.
34. Sharkey DJ, Tremellen KP, Jasper MJ, Gemzell-Danielsson K, Robertson SA. Seminal fluid induces leukocyte recruitment and cytokine and chemokine mRNA expression in the human cervix after coitus. J Immunol 2012; 188:2445-54.
35. Fichorova RN, Tucker LD, Anderson DJ. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis 2001; 184:418-28.
36. Kyongo JK, Jespers V, Goovaerts O, et al. Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PloS One 2012; 7:e43951.
37. Scott ME, Shvetsov YB, Thompson PJ, et al. Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study. Int J Cancer 2013; 133:1187-96.
38. Kleppa E, RamsuranV, Zulu S, et al. Effect of female genital schistosomiasis and anti-schistosomal treatment on monocytes, CD4+ T-cells and CCR5 expression in the female genital tract. PLoS One 2014; 9:e98593.
39. Su HI, Schreiber CA, Fay C, et al. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides. Contraception 2011; 84:525-32.
40. Ryckman KK,Williams SM, Krohn MA, Simhan HN. Racial differences in cervical cytokine concentrations between pregnant women with and without bacterial vaginosis. J Repro Immunol 2008; 78:166-71.
41. Zabaleta J, Schneider BG, Ryckman K, et al. Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother 2008; 57:107-14.